Pharmaceutical compound to boost anti-tumor activity
Selective inhibition and multiple delivery systems. Compound to boost anti-tumor activity that selectively inhibits production of immunosuppressor cells. Because it is selective, the compound does not affect the function of cells responsible for immune response during cancer treatment.
PI BR 10 2020 024609 7
Marcio Chaim Bajgelman | Andrea Johanna Manrique-Rincón